Advice
following an abbreviated submission:
testosterone gel (Testavan®) is accepted for restricted use within NHSScotland.
Indication under review: testosterone replacement therapy for adult male hypogonadism, when testosterone deficiency has been confirmed by clinical features and biochemical tests.
SMC restriction: patients requiring a transdermal delivery system.
Testosterone (Testavan®) is an alternative to another testosterone transdermal preparation and costs less.
Download detailed advice356KB (PDF)
Medicine details
- Medicine name:
- testosterone (Testavan)
- SMC ID:
- SMC2152
- Indication:
- For replacement therapy for adult male hypogonadism, when testosterone deficiency has been confirmed by clinical features and biochemical tests.
- Pharmaceutical company
- Ferring Pharmaceuticals Ltd
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Restricted
- Date advice published
- 08 April 2019